MedTrace Logo

Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes

NCT03747978 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-11-20

No results posted yet for this study

Summary

This was a double-blinded randomized controlled trial of 24-hour blood pressure control in sub Saharan type 2 diabetes patients, newly diagnosed for hypertension. They were allocated to receive either a fixed combination of perindopril + amlodipine or perindopril + indapamide for 42 days.

Conditions

Interventions

DRUG

Perindopril and Amlodipine

Fixed combination of Perindopril 5mg and Amlodipine 5mg

DRUG

Perindopril-indapamide

Perindopril 5mg and Indapamide 1.25mg

Sponsors & Collaborators

  • University of Yaounde 1

    collaborator OTHER

  • Yaounde Central Hospital

    lead OTHER_GOV

Principal Investigators

  • Eugene Sobngwi, MD, PhD · Yaounde Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-01
Primary Completion
2017-05-30
Completion
2017-05-30

Countries

  • Cameroon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03747978 on ClinicalTrials.gov